Zoetis Inc. (ZTS)

146,50 -6,61 (-4,32%) Börsenschluss: 04:00PM EDT

Zoetis Inc.

10 Sylvan Way
Parsippany, NJ 07054
United States
973 822 7000
https://www.zoetis.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 14.100

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Ms. Kristin C. Peck	CEO & Director	3,54M	5,2M	1971
Mr. Wetteny N. Joseph	Executive VP & CFO	1,6M	N/A	1972
Ms. Wafaa Mamilli	EVP, Chief Digital & Tech. Officer, Group President for China, Brazil and Preci. Animal Health	1,36M	N/A	1967
Dr. Robert J. Polzer Ph.D.	Executive VP and President of Research & Development	1,18M	54,13k	1969
Mr. Steven Frank	Vice President of Investor Relations	N/A	N/A	N/A
Mr. William Price	VP & Chief Communications Officer	N/A	N/A	N/A
Ms. Jeannette Ferran Astorga	Executive VP of Corporate Affairs & Communications and Chief Sustainability Officer	N/A	N/A	1975
Mr. Nick Ashton	Executive VP and President of Global Manufacturing & Supply	N/A	N/A	1973
Mr. Jamie Brannan	Executive VP and Group President International Operations of Aquaculture & Global Diagnostics	N/A	N/A	1973
Ms. Rimma Driscoll	Head of Global Strategy, Commercial & Business Development and Global BioDevices	N/A	N/A	1974

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Corporate Governance

Zoetis Inc.s ISS Governance QualityScore, Stand 1. April 2024, lautet 3. Die grundlegenden Scores sind Audit: 5, Vorstand: 2, Shareholderrechte: 7, Kompensation: 2.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.